Romain Oger

Nantes, 44000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

TAP1 deficiency reshapes tumor antigenicity and enables CD8 T cell targeting in colorectal cancer.

TAP1 deficiency reshapes tumor antigenicity and enables CD8 T cell targeting in colorectal cancer.

Journal: Molecular therapy. Oncology

Published: January 28, 2026

Defining the Immune Checkpoint Landscape in Human Colorectal Cancer Highlights the Relevance of the TIGIT/CD155 Axis for Optimizing Immunotherapy.

Defining the Immune Checkpoint Landscape in Human Colorectal Cancer Highlights the Relevance of the TIGIT/CD155 Axis for Optimizing Immunotherapy.

Journal: Cancers

Published: August 04, 2022

Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer.

Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer.

Journal: Oncoimmunology

Published: March 17, 2022

A novel and efficient approach to high-throughput production of HLA-E/peptide monomer for T-cell epitope screening.

A novel and efficient approach to high-throughput production of HLA-E/peptide monomer for T-cell epitope screening.

Journal: Scientific reports

Published: June 21, 2021

High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2.

High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2.

Journal: bioRxiv : the preprint server for biology

Published: May 20, 2021

The Caspase-1/IL-18 Axis of the Inflammasome in Tumor Cells: A Modulator of the Th1/Tc1 Response of Tumor-Infiltrating T Lymphocytes in Colorectal Cancer.

The Caspase-1/IL-18 Axis of the Inflammasome in Tumor Cells: A Modulator of the Th1/Tc1 Response of Tumor-Infiltrating T Lymphocytes in Colorectal Cancer.

Journal: Cancers

Published: November 30, 2020

High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2.

High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2.

Journal: European journal of immunology

Published: November 17, 2020

Transcriptomic features of tumour-infiltrating CD4lowCD8high double positive αβ T cells in melanoma.

Transcriptomic features of tumour-infiltrating CD4lowCD8high double positive αβ T cells in melanoma.

Journal: Scientific reports

Published: December 18, 2019

The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression.

The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: March 28, 2019

Corrigendum: Broad Impairment of Natural Killer Cells From Operationally Tolerant Kidney Transplanted Patients.

Corrigendum: Broad Impairment of Natural Killer Cells From Operationally Tolerant Kidney Transplanted Patients.

Journal: Frontiers in immunology

Published: March 01, 2018

HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition.

HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition.

Journal: PLoS pathogens

Published: December 06, 2017

Broad Impairment of Natural Killer Cells from Operationally Tolerant Kidney Transplanted Patients.

Broad Impairment of Natural Killer Cells from Operationally Tolerant Kidney Transplanted Patients.

Journal: Frontiers in immunology

Published: September 18, 2017

Showing 1-12 of 17

Last Updated: 09/26/2026